Correction: Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial.

Correction: Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial. Clin Cancer Res. 2020 Sep 15;26(18):5048 Authors: Tang B, Chi Z, Chen Y, Liu X, Wu D, Chen J, Song X, Wang W, Dong L, Song H, Wu H, Feng H, Yao S, Qin S, Zhang X, Guo J PMID: 32934029 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32934029?dopt=Abstract

Source: Clinical Cancer Research - September 14, 2020 Category: Cancer & Oncology Authors: Tang B, Chi Z, Chen Y, Liu X, Wu D, Chen J, Song X, Wang W, Dong L, Song H, Wu H, Feng H, Yao S, Qin S, Zhang X, Guo J Tags: Clin Cancer Res Source Type: research

More News: Cancer | Cancer & Oncology | Melanoma | Skin Cancer